A Conversation with an Ambulatory CDI Program Manager
Nancy Koors and Mary Stanfill sit down with ChristianaCare’s Ambulatory CDI Program Manager to discuss UASI’s Risk Adjustment Maturity Model.
Nancy Koors and Mary Stanfill sit down with ChristianaCare’s Ambulatory CDI Program Manager to discuss UASI’s Risk Adjustment Maturity Model.
November’s CDI Scenario covers neurogenic shock and spinal shock. A 58 year old male enters the ER after hitting his head.
October’s CDI scenario covers pneumonia and COVID-19. A 60 year old male patient presents with COVID and worsening hypoxia.
Topic: Pathological Fracture Scenario: 82 year old female presented with right hip pain after ground level fall History & Physical: HPI: 82 year old female… Read More »Monthly CDI Scenario Discussion – January 2020
Clinical documentation improvement (CDI) — particularly in outpatient settings — continues to be a top priority for US healthcare organizations as they prepare for their… Read More »UASI Experts to Present “Creating and Retaining the Best CDI Team” at AHIMA 2018
For many years, coding audits have been commonly-employed to make their revenue cycles more efficient. Now, they’re becoming mission-critical. In a new, peer-reviewed article out… Read More »UASI in JAHIMA: “Auditing Across the Continuum”
10 Key considerations to evaluate remote CDI readiness “Will I ever have an opportunity to work from home?” It’s a question often asked by Clinical… Read More »Best Practices for Building a Remote CDI Model
Unspecified diagnosis coding continues to be a problem in the US healthcare industry. For many organizations, overuse of nonspecific diagnosis codes has resulted in reimbursement delays and, in some cases, preventable claim denials.
In the January 2018 edition of the peer-reviewed Journal of the American Health Information Management Association (JAHIMA), UASI corporate trainer Natalie Satori, MEd, RHIA, published an article that seeks to clear up some of the confusion surrounding clinical criteria, as they pertain to coding guidelines and clinical validation specifically for sepsis.